The effect of BPC 157 on muscle function is combined with the counteraction of increased levels of pro-inflammatory and pro-cachectic cytokines and of downstream pathways to abolish muscle cachexia [2]
Similarly, in lung cancer, tumor suppressor genes such as p16, RASSF1A, and KCNK3 undergo methylation-induced silencing, promoting tumor progression
The Science Behind Combining BPC-157 and TB-500 When combined in a BPC-157 TB-500 nasal spray , these peptides work complementarily: The combination addresses both the vascular components of healing (BPC-157) and the cellular migration necessary for tissue repair (TB-500), creating a more complete regenerative response than either peptide alone [4]
Minimal response may warrant increasing by 50-100mcg
Because quality sleep is foundational to recovery, hormonal balance, and cellular repair, DSIP is sometimes considered as part of a broader peptide protocol alongside other recovery-focused therapies.
Research overview Other vial-size protocols Related protocols and comparisons BPC-157 + TB-500 (10 mg Blend) Dosage Protocol BPC-157 + TB-500 (20 mg Blend) Dosage Protocol TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol Tri-Heal (45 mg Blend) Dosage Protocol GLOW (70 mg Blend) Dosage Protocol KLOW (80 mg Blend) Dosage Protocol GHK-Cu (50 mg Vial) Dosage Protocol GHK-Cu (100 mg Vial) Dosage Protocol
